Applied Genetic Technologies Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
18.13 M |
Public Float |
17.03 M |
Applied Genetic Technologies Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.1 |
Market Cap |
$68.66 M |
Shares Outstanding |
18.17 M |
Public Float |
12.38 M |
Address |
14193 NW Alachua Florida 32615 United States |
Employees | - |
Website | http://www.agtc.com |
Updated | 07/08/2019 |
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. |